Supporters and fundraisers news

Awareness Month 2015 – what a month it was!

IMG_3085Wow, what an incredible awareness month!  Not only was it all hands on deck in the Pancreatic Cancer Action office but we have also seen some amazing awareness initiatives taking place across the country.

We would like to take this opportunity to say a huge thank you to all those who have made November 2015 the most successful Pancreatic Cancer Awareness Month in the UK yet. We are truly grateful to every one of you who fundraised, donated,  arranged for a landmark to light up purple, raised awareness with our Turn it Purple twibbon, watched and shared our World Pancreatic Cancer Day Friday 13th video, and much, much more to raise widespread awareness.

The month got off to a fantastic start with our annual Striding for Survival walk, which took place at Virginia Water in Surrey on  Sunday 1st November.  It was a beautiful day with over 87 people striding in memory of those who are battling or lost their battle with the disease.

In the evening, numerous landmarks across the UK lit up purple to mark the start of awareness month and our social media feed was full of stunning pictures sent in by our supporters.

Before the month even started, we had sent out over a hundred action packs, containing awareness material and merchandise, that we have seen displayed in workplaces, shops, schools, pubs and health centres across the country.  Some people used the material to set up awareness stands, including at GP conferences and in Supermarkets, handing out information and talking about pancreatic cancer.

The month also saw our chief executive and rare pancreatic cancer survivor, Ali Stunt, travelling across Europe during the second week of Pancreatic Cancer Awareness Month 2015, educating primary care professionals, scientists and politicians across Europe.

Thank you to everyone one for their hard work during November 2015.  We really appreciate your dedication to raising awareness and funds to drive change for current and future pancreatic cancer patients.